Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 30 results.
User Information
Export Records
  1. 1.   The common variable immunodeficiency IgM repertoire narrowly recognizes erythrocyte and platelet glycans
  2. Le Coz, Carole; Trofa, Melissa; Butler, Dorothy L; Yoon, Samuel; Tian, Tian; Reid, Whitney; Cruz Cabrera, Emylette; Knox, Ainsley V C; Khanna, Caroline; Sullivan, Kathleen E; Heimall, Jennifer; Takach, Patricia; Fadugba, Olajumoke O; Lawrence, Monica; Jyonouchi, Soma; Hakonarson, Hakon; Wells, Andrew D; Handler, Steven; Zur, Karen B; Pillai, Vinodh; Gildersleeve,Jeffrey; Romberg, Neil
  3. The Journal of Allergy and Clinical Immunology. 2024, Apr 29;
  1. 2.   Tools and tactics to define specificity of metabolic chemical reporters
  2. Mukherjee, Mana Mohan; Bond, Michelle R; Abramowitz, Lara K; Biesbrock, Devin; Woodroofe, Carolyn C; Kim, Eun Ju; Swenson, Rolf E; Hanover, John A
  3. Frontiers in Molecular Biosciences. 2023, Dec 7; 10: 1286690.
  1. 3.   Networks of HIV-1 Envelope Glycans Maintain Antibody Epitopes in the Face of Glycan Additions and Deletions
  2. Seabright, Gemma E; Cottrell, Christopher A; van Gils, Marit J; D'addabbo, Alessio; Harvey, David J; Behrens, Anna-Janina; Allen, Joel D; Watanabe, Yasunori; Scaringi, Nicole; Polveroni, Thomas M; Maker, Allison; Vasiljevic, Snezana; De Val Alda,Natalia; Sanders, Rogier W; Ward, Andrew B; Crispin, Max
  3. Structure (London, England : 1993). 2020, AUG 4; 28(8): 897-+.
  1. 4.   The N-acetyl-binding pocket of N-acetylglucosaminyltransferases also accommodates a sugar analog with a chemical handle at C2
  2. Pasek, M.; Ramakrishnan, B.; Boeggeman, E.; Mercer, N.; Dulcey, A. E.; Griffiths, G. L.; Qasba, P. K.
  3. Glycobiology. 2012, Mar; 22(3): 379-388.
  1. 5.   The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells
  2. Alexandre, K. B.; Gray, E. S.; Mufhandu, H.; McMahon, J. B.; Chakauya, E.; O'Keefe, B. R.; Chikwamba, R.; Morris, L.
  3. Virology. 2012, Feb; 423(2): 175-186.
  1. 6.   Modifications of Glycans: Biological Significance and Therapeutic Opportunities
  2. Muthana, S. M.; Campbell, C. T.; Gildersleeve, J. C.
  3. Acs Chemical Biology. 2012, Jan; 7(1): 31-43.
  1. 7.   Molecular Aspects of HTLV-1 Entry: Functional Domains of the HTLV-1 Surface Subunit (SU) and Their Relationships to the Entry Receptors
  2. Jones, K. S.; Lambert, S.; Bouttier, M.; Benit, L.; Ruscetti, F. W.; Hermine, O.; Pique, C.
  3. Viruses-Basel. 2011, Jun; 3(6): 794-810.
  1. 8.   Unconventional Secretion of Tissue Transglutaminase Involves Phospholipid-Dependent Delivery into Recycling Endosomes
  2. Zemskov, E. A.; Mikhailenko, I.; Hsia, R. C.; Zaritskaya, L.; Belkin, A. M.
  3. Plos One. 2011, Apr; 6(4): 14.
  1. 9.   The Antiretroviral Lectin Cyanovirin-N Targets Well-Known and Novel Targets on the Surface of Entamoeba histolytica Trophozoites
  2. Carpentieri, A.; Ratner, D. M.; Ghosh, S. K.; Banerjee, S.; Bushkin, G. G.; Cui, J. K.; Lubrano, M.; Steffen, M.; Costello, C. E.; O'Keefe, B.; Robbins, P. W.; Samuelson, J.
  3. Eukaryotic Cell. 2010, Nov; 9(11): 1661-1668.
  1. 10.   Interaction between the HTLV-I envelope and cellular proteins: impact on virus infection and restriction
  2. Ilinskaya, A.; Heidecker, G.; Jones, K.
  3. Future Medicinal Chemistry. 2010, Nov; 2(11): 1651-1668.
  1. 11.   Current concepts regarding the HTLV-1 receptor complex
  2. Ghez, D.; Lepelletier, Y.; Jones, K. S.; Pique, C.; Hermine, O.
  3. Retrovirology. 2010, Nov; 7: 11.
  1. 12.   Evaluation of human antibody responses to keyhole limpet hemocyanin on a carbohydrate microarray
  2. Oyelaran, O.; Gildersleeve, J. C.
  3. Proteomics Clinical Applications. 2010, Mar; 4(3): 285-294.
  1. 13.   Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins
  2. Chen, W. Z.; Zhu, Z. Y.; Liao, H. X.; Quinnan, G. V.; Broder, C. C.; Haynes, B. F.; Dimitrov, D. S.
  3. Viruses-Basel. 2010, Feb; 2(2): 547-565.
  1. 14.   The Receptor Complex Associated with Human T-Cell Lymphotropic Virus Type 3 (HTLV-3) Env-Mediated Binding and Entry Is Distinct from, but Overlaps with, the Receptor Complexes of HTLV-1 and HTLV-2
  2. Jones, K. S.; Huang, Y. K.; Chevalier, S. A.; Afonso, P. V.; Petrow-Sadowski, C.; Bertolette, D. C.; Gessain, A.; Ruscetti, F. W.; Mahieux, R.
  3. Journal of Virology. 2009 83(10): 5244-5255.
  1. 15.   HIV-1 and microvesicles from T cells share a common glycome, arguing for a common origin
  2. Krishnamoorthy, L.; Bess, J. W.; Preston, A. B.; Nagashima, K.; Mahal, L. K.
  3. Nature Chemical Biology. 2009 5(4): 244-250.
  1. 16.   HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF(165)
  2. Lambert, S.; Bouttier, M.; Vassy, R.; Seigneuret, M.; Petrow-Sadowski, C.; Janvier, S.; Heveker, N.; Ruscetti, F. W.; Perret, G.; Jones, K. S.; Pique, C.
  3. Blood. 2009 113(21): 5176-5185.
  1. 17.   Glycosylation of gp41 of Simian Immunodeficiency Virus Shields Epitopes That Can Be Targets for Neutralizing Antibodies
  2. Yuste, E.; Bixby, J.; Lifson, J.; Sato, S.; Johnson, W.; Desrosiers, R.
  3. Journal of Virology. 2008 82(24): 12472-12486.
  1. 18.   High-throughput carbohydrate microarray profiling of 27 antibodies demonstrates widespread specificity problems
  2. Manimala, J. C.; Roach, T. A.; Li, Z. T.; Gildersleeve, J. C.
  3. Glycobiology. 2007, Aug; 17(8): 17C-23C.
  1. 19.   GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1
  2. Takenouchi, N.; Jones, K. S.; Lisinski, I.; Fugo, K.; Yao, K.; Cushman, S. W.; Ruscetti, F. W.; Jacobson, S.
  3. Journal of Virology. 2007, Feb; 81(3): 1506-1510.
  1. 20.   Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells
  2. Jones, K. S.; Fugo, K.; Petrow-Sadowski, C.; Huang, Y.; Bertolette, D. C.; Lisinski, I.; Cushman, S. W.; Jacobson, S.; Ruscetti, F. W.
  3. Journal of Virology. 2006, Sep; 80(17): 8291-8302.
  1. 21.   Mutant glycosyltransferases assist in the development of a targeted drug delivery system and contrast agents for MRI
  2. Qasba, P. K.; Ramakrishnan, B.; Boeggeman, E.
  3. Aaps Journal. 2006 8(1): E190-E195.
  1. 22.   Heparan sulfate Proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4(+) T cells
  2. Jones, K. S.; Petrow-Sadowski, C.; Bertolette, D. C.; Huang, Y.; Ruscetti, F. W.
  3. Journal of Virology. 2005, OCT; 79(20): 12692-12702.
  1. 23.   Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A
  2. Witvrouw, M.; Fikkert, V.; Hantson, A.; Pannecouque, C.; O'Keefe, B. R.; McMahon, J.; Stamatatos, L.; De Clercq, E.; Bolmstedt, A.
  3. Journal of Virology. 2005, JUN; 79(12): 7777-7784.
  1. 24.   Heparan sulfate proteoglycans are critical for efficient attachment and entry of HTLV-I into Cd4+ T cells
  2. Jones, K. S.; Petrow-Sadowski, C.; Huang, Y.; Bertolette, D.; Fugo, K.; Takenouchi, N.; Grant, C. W.; Yao, K.; Jacobson, S.; Ruscetti, F. W.
  3. Aids Research and Human Retroviruses. 2005, MAY; 21(5): 459, Abstract O65-459, Abstract O65.
  1. 25.   Substrate-induced conformational changes in glycosyltransferases
  2. Qasba, P. K.; Ramakrishnan, B.; Boeggeman, E.
  3. Trends in Biochemical Sciences. 2005, JAN; 30(1): 53-62.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel